SUMMARY The theoretical and practical reasons for replacing the terms "cervical dysplasia" and "cervical carcinoma in situ" by the single diagnostic entity of "cervical intraepithelial neoplasia" are reviewed and the advantages and drawbacks of this newer terminology discussed. The histological characteristics and cytological features of the various grades of cervical intraepithelial neoplasia are described and the differential diagnosis of this lesion is considered.
In 1969 Govan and his colleagues gave a detailed account of the classification, nomenclature, histological features, and cytological characteristics of those various abnormalities of cervical squamous epithelium which fall short of a frankly invasive carcinoma.' This paper has served well as a guideline, and reference text, for many pathologists and cytologists but in the intervening years our knowledge of cervical pathology has expanded and our understanding and interpretation of cervical epithelial abnormalities has altered. One result of this changing appreciation of cervical lesions has been the introduction of a new terminology: this change has been welcomed by some, but resisted by, and indeed proved unacceptable to, others, with the result that whilst some pathologists and cytologists are currently couching their reports in terms of the new nomenclature others are still using the older and better established terminology. The concurrent use of two systems of nomenclature for cervical lesions is unsatisfactory and prone to cause confusion and misunderstanding.
As advocates of the new system of terminology it is our aim in this paper to detail the conceptual and practical reasons for adopting a new nomenclature, to consider the possible objections to its use, and to redefine the histological and cytological features of abnormalities of the cervical squamous epithelium in terms of this nomenclature.
Nomenclature of cervical epithelial abnormalities
A fundamental division of cervical squamous epithelial abnormalities can be made between those which lack any potential for evolving into an invasive squamous cell carcinoma and those in which there is a significant risk of progression to an invasive Accepted for publication 20 July 1981 neoplasm. The first group of banal changes includes such entities as basal cell hyperplasia, reserve cell hyperplasia, immature squamous metaplasia, and mature squamous metaplasia, all of which are benign, indeed usually physiological, conditions unaccompanied by any increased risk of invasive carcinoma. Epithelial abnormalities that are potentially capable of progression into an invasive neoplasm have traditionally been categorised either as dysplasia or as carcinoma in situ, dysplastic changes within the epithelium being graded as of mild, moderate, or severe degree.
The new nomenclature applies only to those cervical epithelial abnormalities associated with an increased risk of invasive carcinoma, all of which are now put into the single diagnostic category of cervical intraepithelial neoplasia (CIN).2, 3 Three grades of abnormality are recognised: CIN I which corresponds to mild dysplasia; CIN II It is thus clear that dysplasia is an ill-understood and imprecisely defined abnormality, that grading of dysplasia is a highly subjective and arbitrary exercise, that the distinction between dysplasia and carcinoma in situ is often only a matter of opinion and that pathologists can achieve little consistency either with their colleagues diagnoses or in their own opinions. These problems would be of little account were it not for the fact that the use of the terms "dysplasia" and "carcinoma in situ" has implanted into the minds of many pathologists and gynaecologists the impression that cervical dysplasia is, in an undefined fashion, a different disease process to carcinoma in situ. It 10 This unity of basic cellular abnormality is further emphasised by studies of the biological behaviour of dysplasia. It is widely recognised that between 45 and 70% of cases of carcinoma in situ will eventually progress to an invasive carcinoma20 21 and it is also recognised that carcinoma in situ is a condition which rarely, if ever, spontaneously regresses: dysplasia, on the other hand, has been thought to undergo spontaneous regression quite frequently and is often regarded as a very infrequent precursor of carcinoma in situ with little possibility of evolving into an invasive carcinoma. To a considerable extent these impressions are based on early prospective studies in which it was not realised that a cervical punch biopsy not infrequently removes all the abnormal epithelium and is therefore curative: even in cases in which complete excision is not achieved the healing process which follows the trauma of biopsy may eradicate the epithelial lesion. Under these circumstances it was not fully appreciated that post-biopsy disappearance of the cervical lesion usually represents a cure and not necessarily, or even usually, spontaneous regression, this leading to a serious misinterpretation of the biological behaviour of unbiopsied dysplasia: the magnitude of this error is shown by Koss's study6 in which nearly 40 % of cases of dysplasia diagnosed by punch biopsy of the cervix subsequently disappeared. It is noteworthy, however, that in this study 42-3 % of cases of dysplasia progressed to carcinoma in situ despite the intervention of a biopsy whilst nearly 4 % evolved into an invasive carcinoma. The natural history of dysplasia is best demonstrated by a combination of cytology and colposcopy with the avoidance of biopsy: in such a study Richart and Barron22 showed that 50 % of cases of dysplasia eventually progress to a carcinoma in situ, that 28 % of cases advance to a higher degree of dysplasia and 22% of cases of dysplasia persist unchanged; spontaneous regression of dysplasia was found to be extremely rare and occurred only in a very small proportion (6 %) of cases of mild dysplasia. If it is accepted that approximately 500% of cases of carcinoma in situ eventually progress to an invasive carcinoma and that 50 % of cases of dysplasia evolve into a carcinoma in situ it becomes clear that approximately 25 % of cases of dysplasia will eventually develop into an invasive neoplasm. It is therefore apparent that dysplasia cannot be dismissed as an innocuous lesion, a point further emphasised by the now firmly established fact that an invasive carcinoma can develop directly from a dysplasia, of even mild or moderate grade, without any necessary prior transition to a carcinoma in situ.5
In view of these facts it seems reasonable to discard the terminology suggestive of a two-stage evolution of intraepithelial carcinoma, to accept that all cases of "dysplasia" are, irrespective of grade, a form of intraepithelial neoplasm and to introduce the term cervical intraepithelial neoplasia to encompass both dysplasia, of all grades, and carcinoma in SitU.2 3 Cervical intraepithelial neoplasia may be defined as "a spectrum of intraepithelial change which begins as a generally well differentiated neoplasm which has traditionally been classified as mild dysplasia and ends with invasive carcinoma."'10 It will be appreciated that this definition hints at dysplasia being a well differentiated carcinoma in situ and this is a view which has been strongly espoused by Burghardt.5 It is of value for descriptive and epidemiological purposes to 
lium show nuclear abnormalities, the cells in the upper and middle thirds of the epithelium undergo cytoplasmic differentiation (Fig. 1) . Thus, at all levels of the epithelium, the nuclei tend to have prominent nucleoli and be pleomorphic, of irregular outline, enlarged and hyperchromatic with a coarse granular or filamentous chromatin pattern. The cells in the lower third, or less, of the epithelium show no evidence of cytoplasmic differentiation or of orderly stratification, lack clearly defined boundaries and have a high nucleocytoplasmic ratio with nuclear crowding whilst those in the middle and upper thirds of the epithelium show, to a variable degree, evidence of stratification and of cytoplasmic maturation with a decreasing nucleocytoplasmic ratio. Hence the surface cells may show a normal degree of maturation and can differ from normal cells only by their possession of abnormal nuclei. Aberrant keratinisation of individual cells is sometimes seen whilst mitotic figures are relatively uncommon, are generally confined to the lower third of the epithelium and are usually of normal form. CIN II The histological features of CGN II are similar to those of CIN I except that undifferentiated non-stratified cells with pleomorphic nuclei, and a high nucleocytoplasmic ratio extend beyond the lower third of the epithelium but not into the upper third (Fig. 2) . The cells in the upper third of the epithelium undergo a variable degree of stratification and of cytoplasmic differentiation. Mitotic figures are present in the lower two-thirds of the epithelium and are not uncommonly of abnormal form. CIN III In this condition undifferentiated, nonstratified, basaloid cells with nuclear crowding, 5 indistinct boundaries and a high nucleocytoplasmic ratio occupy more than two thirds, or the full thickness, of the epithelium (Fig. 3) In a third variant of CIN LII the epithelium is largely or wholly occupied by cells of relatively low nucleocytoplasmic ratio having well defined cell boundaries: there may be well marked surface keratosis. There is, however, a complete disorganisation of growth pattern and lack of stratification and polarity (Fig. 5) The most severe reactive changes, and those which most closely mimic CIN, are associated, in both our own experience and that of others,25 with the presence of an intrauterine contraceptive device (IUCD). In these cases the epithelial cells may show severe cellular and nuclear pleomorphism, an increased nucleocytoplasmic ratio, prominent nucleoli and cytoplasmic vacuolation. There is, however, usually a well marked inflammatory cell reaction and removal of the device is followed by a reversion to normal: it is important that the pathologist or cytologist is aware of the presence of an IUCD in such cases.
Atrophic squamous cervical epithelium is also sometimes confused with CIN. Such an epithelium is thin and the basal cells, which occupy an unduly high * ....
proportion of the epithelial thickness, often have prominent nuclei and nucleoli. Mitotic figures are, however, seen only in the basal layers of the epithelium whilst the typical nuclear characteristics of neoplasia are absent.
Condylomata of the cervix are not uncommon and may present a problem in differential diagnosis, in so far as the koilocytosis, multinucleation, individual cell keratinisation and occasional mild cellular atypia which are characteristic of this viral lesion may give a false impression of CIN. This diagnostic difficulty is more likely to arise with the flat condyloma than with the papillary form of this lesion but, again, the absence of nuclei showing the typical features of neoplasia and of abnormal mitotic figures serve to exclude CIN. It has to be accepted, however, that CIN can, and not infrequently does, develop in a condylomatous lesion; condylomata merit careful study to exclude complicating CIN and, conversely, all areas of CIN should be scrutinised for features suggestive of the lesion having developed in a pre-existing condyloma.
Cytological diagnosis of CIN
Cervical intraepithelial neoplasia is generally asymptomatic and naked eye inspection of the cervix may reveal no abnormality. Consequently the understanding, interpretation, and diagnosis of these lesions stems from the introduction of exfoliative cytology in cancer diagnosis.26
Cells which are present in the cervical smear reflect the cells exfoliating from the surface epithelium of the cervix and the cell population is also influenced by the rate of exfoliation. It is well known that all degrees of intraepithelial neoplasia can coexist and cells from these lesions together with normal squamous and columnar cells will be found in the smear.
Prediction of the probable histological picture depends on assessment of the whole smear but for communication and standardisation between cytology laboratories it is necessary to identify individual cells using a standard terminology. It is suggested that the recommendations of the Working Party of the British Society for Clinical Cytology27 are followed together with the finer modifications used by Spriggs and Boddington.28
CYTOLOGICAL FEATURES OF CIN

Identification of dyskaryotic cells in the smear
The appearance of the nucleus distinguishes dyskaryotic cells (Fig. 6 ) from normal cells and from malignant cells, the term "malignant" cell being used only when there is confidence that the cell is shed from an invasive lesion. The nucleus of a dyskaryotic cell is large and hyperchromatic, the chromatin pattern is irregular in the sense that it shows a granular condensation of chromatin but the arrangement of the condensed chromatin is uniform without the irregular areas of clearing seen in the nucleus of a malignant cell. The nucleus is round, oval or, sometimes, elongated and the nuclear outline can be smooth or finely wrinkled. The degree of differentiation of the cytoplasm is important in the final assessment of the whole smear. Normal cytoplasmic differentiation is seen in mature (superficial and intermediate) and parabasal dyskaryotic cells (Fig. 7) and in these the appearance of the cytoplasm is similar to that seen in the equivalent normal cell but the nucleus is relatively large with the features described above. Dyskaryotic nuclei can also be recognised in cells with no cytoplasmic differentiation (Fig. 8) . These cells have a high nucleocytoplasmic ratio and they can occur singly, in small groups, in coherent masses or as sheets. They will be referred to as undifferentiated dyskaryotic cells.
Interpretation of the cervical smear depends upon an assessment of the relative numbers of the different types of dyskaryotic cells present and it is usual to report the "worst" histological lesion anticipated 
